Figure 1.
miR-491-5p inhibits cell proliferation and promotes apoptosis in gastric cancer cells. (a) qRT-PCR was performed to examine miR-491-5p expression in 22 paired human gastric cancer and adjacent normal tissues. The expression of miR-491-5p was normalized to U6. (b) qRT-PCR analysis of miR-491-5p expression in normal gastric mucosal and gastric cancer cells and normalized against U6 RNA. (c) The effects miR-491-5p on gastric cancer cell proliferation were determined by MTT assay after transfection of miR-491 or control vector at 24, 48, and 72 h. (d) Representative results of a colony formation assay for MKN45/SGC-7901 cells after miR-491 transfection. (e) Apoptosis was detected by annexin-V/propidium iodide combined labeling flow cytometry in MKN45/SGC-7901 cells 48 h after transfection with miR-491 or control vector. Apoptotic evaluation was carried out by calculating the percentage of apoptotic cells. (f) MKN45/SGC-7901 cells were transfected with miR-491 vector and control vector. After 48 h, cell cycle distribution was analyzed by flow cytometry. A histogram indicates the percentage of cells in G0/G1, S, and G2/M cell cycle phases. (g) The expression of pro-caspase 3, active caspase 3, cleaved PARP, BCL-2, CDK2, CCNA2, and β-catenin was analyzed by western blot (*P<0.05, **P<0.01)